BlackRock, Inc. 13D and 13G filings for Laboratory Corporation of America Holdings:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-30 2:38 pm Sale | 2023-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 10,488,875 12.400% | -2,867,451 (-21.47%) | Filing |
| 2023-02-10 11:28 am Unchanged | 2022-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 13,356,326 13.000% | 0 (Unchanged) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 13,356,326 13.000% | 0 (Unchanged) | Filing |
| 2023-01-20 5:17 pm Purchase | 2022-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 13,356,326 13.000% | 2,057,912 (+18.21%) | Filing |
| 2022-03-09 5:18 pm Purchase | 2022-02-28 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 11,298,414 10.400% | 1,666,999 (+17.31%) | Filing |
| 2022-02-01 5:14 pm Purchase | 2021-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 9,631,414 8.600% | 514,309 (+5.64%) | Filing |
| 2021-01-29 5:22 pm Sale | 2020-12-31 | 13G | Laboratory Corporation of America Holdings LH | BlackRock Inc. BLK | 9,117,106 8.000% | -1,190,933 (-11.55%) | Filing |